1. Page 1 of 2
COLIN MANSFIELD
Address: Lyon, France
Citizenship: British
PROFESSIONAL HISTORY
Principal Medical Writer and IP Manager at AB Science, Paris, France. (June 2008 - present)
Marie Curie Research Fellow at Institut des Nanotechnologies, ECL, Lyon, France. (Nov 2006 – June 2008)
Research Associate at NRC, Institute for Biodiagnostics, Winnipeg, Canada. (2001 - 2006)
PROFESSIONAL SKILLS AND EXPERIENCE
Principal Medical Writer for a fully integrated pharmaceutical company that develops targeted therapies in the
fields of oncology, immune-mediated diseases and neurological disorders. This entails the drafting, review and
editing of clinical study documentation, regulatory submission documentation, and medical communications. More
specifically:
Articles for peer-review journals; submission planning; conference abstracts, slide-sets and posters; scientific
promotional, webpage and educational materials; press releases.
Marketing authorization (eCTD module 2) and orphan drug designation applications, response to health
authorities and affiliate questions, regulatory annual reports (FDA and EMA), clinical study reports according
to ICH, Investigator Brochure, scientific rationale, study protocols, informed consent forms, SOPs.
Participant at meetings for EMA centralized marketing authorization application; pre-submission through to
Scientific Advisory Group appeal hearings.
Responsible for recruitment of new medical writers and regulatory affairs staff.
Intellectual Property Manager primarily entailing drafting and prosecution of pharmaceutical method-of-use
patents, intellectual property strategic planning, management of current patents and patent applications,
identification of inventions and filing of new patents.
Scientific Editor of a book published by Springer Press as part of their Methods in Molecular Biology Series on
the topic of microfluidic diagnostics.
Lead Scientist on several projects, including clinical and preclinical studies requiring the collection, analysis and
reporting of data in the fields of nanobiotechnology and biomedical infrared spectroscopy.
Adaptability, self-reliance and teamwork are evident in the breadth of medical/scientific communication tasks
undertaken and the variety of senior and junior staff collaborations.
2. Page 2 of 2
ACADEMIC BACKGROUND
Optical Research Centre
University of Southampton, UK
Ph.D. in Biomedical Physics (1994 - 2000)
Biomedical Physics Group
University of Exeter, UK
M.Sc. Medical Physics (1993 - 1994)
Royal Holloway University of
London, UK
B.Sc. Physics with Astrophysics
2:1 (Hons)
(1990 - 1993)
ACHIEVEMENTS AND FELLOWSHIPS
Authored over 25 articles in peer-reviewed journals including eight as first author and three book chapters.
Medical writing contributions and critical review acknowledged in many others articles.
Book editor: Microfluidic Diagnostics - Methods and Protocols. Series: Methods in Molecular Biology,
Volume 949, 2013. Over 100K chapters downloaded to date. Personal project.
PCT international patent 10 May 2005 (IPSO 1589-1): CD Mansfield and RA Shaw, National Research
Council Canada, “Microfluidic Preconditioning of (Bio)Fluids for Reagent free Infrared Clinical Analysis and
Diagnostics”.
Research funding from the Marie Curie Intra-European Fellowship, “Lab-on-a-chip based analyzers for point-
of-care monitoring of cancer therapy”, 2006: awarded € 161,000.
Research funding from the Manitoba Medical Service Foundation, “Point-of-care measurements for chronic
kidney disease based upon infrared spectroscopy”, 2005: awarded $ 22,000 CDN.
Ph.D. studentship from the Southampton University, UK, 1994: awarded course fees and living allowance.
Studentship from Engineering and the Physical Sciences Research Council, “Medical physics MSc
programme” at Exeter University, UK, 1993: awarded course fees and living allowance.